Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bupivacaine TTS in Chronic Low Back Pain
NCT01096966Phase 2Completed
- Sponsor
- DURECT Corporation
- Start
- Mar 2010
- Primary completion
- Feb 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of bupivacaine in chronic low back pain (CLBP), sponsored by DURECT Corporation. Started Mar 2010; status: completed.
02
Drugs
bupivacaine
03
Conditions
chronic low back pain (CLBP)
Beyond the preview
Go deeper on NCT01096966.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01096966.